交叉反应物质CRM197结合疫苗在感染或未感染HIV的儿童和青少年中诱导白喉毒素中和抗体反应
研究分析了HIV垂直感染儿童青少年(HI)与年龄匹配健康对照(HC)接种脑膜炎球菌C多糖-CRM197结合疫苗后白喉毒素中和抗体(DT-Nab)反应。接种前HI组21例(50%)无保护、仅8例(19%)完全保护,HC组56%完全保护、6例(12%)无保护;接种一剂和两剂后分别有96%的HC和64%的HI受种者获得完全保护。CRM197在两组中均能诱导初次和/或加强应答。
要点
- 接种前HI组50%无白喉保护,仅19%完全保护;HC组56%完全保护。
- 接种一剂和两剂后,96%的HC和64%的HI受种者分别获得完全保护。
- CRM197结合疫苗在HIV感染和未感染儿童青少年中均能诱导初次和/或加强抗体应答。
核心结论
- CRM197能诱导HIV垂直感染儿童青少年和健康对照的初次和/或加强白喉毒素中和抗体应答。
研究设计与样本
- 分析HIV垂直感染儿童青少年(HI)与年龄匹配健康对照(HC)接种脑膜炎球菌C多糖-CRM197结合疫苗后的白喉毒素中和抗体(DT-Nab)反应,并报告DT-Nab与C群脑膜炎球菌杀菌抗体的关联。
主要发现
- 接种前HI组21例(50%)无白喉保护(抗体≤0.01IU/ml),仅8例(19%)完全保护(抗体≥0.1IU/ml)。
- 接种前HC组56%完全保护,6例(12%)无保护。
- 接种一剂和两剂后,96%的HC和64%的HI受种者分别获得完全保护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anti-diphtheria antibody levels decrease with aging, and frequent booster vaccinations are required to maintain herd immunity. We analyzed the diphtheria toxin neutralizing antibody (DT-Nab) response induced by a conjugate vaccine (meningococcal C polysaccharide-CRM197) in HIV-vertically infected (HI) children and adolescents and healthy controls (HC) with matched age. We report the association of DT-Nab with the bactericidal antibodies to serogroup C meningococcus (MenC). Before vaccination, 21 HI patients (50%) had no protection against diphtheria (≤0.01IU/ml of antibody) and only 8 (19%) showed complete protection (≥0.1IU/ml). About half of the HC (56%) had complete protection before immunization and 6 subjects (12%) had no protection against diphtheria. After one and two vaccine injections, 96% of HC and 64% of HI vaccinees, respectively, showed full protection against diphtheria. These data indicate that CRM197 was able to induce primary and/or booster response in both groups of individuals.
引用
- Silva GP, Santos RS, Pereira-Manfro WF, et al. A cross-reacting material CRM197 conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV. Vaccine. 2017. PMID: 28599793. doi:10.1016/j.vaccine.2017.05.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。